Fletcher Biosciences
Pre-clinicalWe start with natural immune proteins and refine them through design — unlocking targeted, programmable therapies for the immune system.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $20.5M
About
We start with natural immune proteins and refine them through design — unlocking targeted, programmable therapies for the immune system.
Biologics
Funding History
2Total raised:$20.5M
Series A$15MNov 15, 2022
Seed$5.5MJun 15, 2021